Almirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European Dermatology Business, Driven by Biologics and Solid Performance of Broad Product Portfolio

View Full Size 

Download

• Full Size JPEG, 750x1153, 445.9 KB
• Small JPEG, 312x480, 170.9 KB
• Preview JPEG, 94x144, 23.5 KB
• Thumbnail JPEG, 47x72, 7.5 KB